NCT00591552

Brief Summary

In an effort to elucidate whether the Harmonic Scalpel will improve sealing lymphatics and decrease lymphatic drainage thereby decreasing the length of time that chest tubes are required and minimizing length of stay; the Harmonic Scalpel will be compared to a control group which uses electrocautery. This study will assess these two different methods to determine if there is a notable decrease in the amount of drainage with one versus the other.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable lung-cancer

Timeline
Completed

Started Dec 2007

Longer than P75 for not_applicable lung-cancer

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2007

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

December 26, 2007

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 11, 2008

Completed
16.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
Last Updated

November 21, 2023

Status Verified

November 1, 2023

Enrollment Period

16.9 years

First QC Date

December 26, 2007

Last Update Submit

November 20, 2023

Conditions

Keywords

Lung cancerLymph node dissection

Outcome Measures

Primary Outcomes (1)

  • Amount of chest tube drainage

    daily

Secondary Outcomes (1)

  • Pleural effusions monitored by chest x-ray.

    Every other day and at four weeks

Study Arms (2)

Group A

ACTIVE COMPARATOR

Electrocautery used for dissection.

Device: Electrocautery

Group B

ACTIVE COMPARATOR

Harmonic Scalpel used for dissection

Device: Harmonic ACE23P Scalpel

Interventions

Lymph node dissection

Group B
Group A

Eligibility Criteria

Age20 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing resection for stage 1, 2 or 3A lung cancer.
  • Patients between the ages of 20-75.

You may not qualify if:

  • History of Congestive Heart Failure.
  • History of renal failure, ie., creatinine greater than 2.2.
  • Patients with bulky or matted lymph nodes in stage 3A.
  • Current pregnancy.
  • Current participation in another study involving an investigational device or drug.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sentara Norfolk General Hospital/Sentara Heart Hospital

Norfolk, Virginia, 23507, United States

RECRUITING

Related Publications (3)

  • Holub Z, Jabor A, Kliment L, Lukac J, Voracek J. Laparoscopic lymph node dissection using ultrasonically activated shears: comparison with electrosurgery. J Laparoendosc Adv Surg Tech A. 2002 Jun;12(3):175-80. doi: 10.1089/10926420260188065.

    PMID: 12184902BACKGROUND
  • Lumachi F, Burelli P, Basso SM, Iacobone M, Ermani M. Usefulness of ultrasound scissors in reducing serous drainage after axillary dissection for breast cancer: a prospective randomized clinical study. Am Surg. 2004 Jan;70(1):80-4.

    PMID: 14964555BACKGROUND
  • Kajiyama Y, Iwanuma Y, Tomita N, Amano T, Hattori K, Tsurumaru M. Sealing the thoracic duct with ultrasonic coagulating shears. Hepatogastroenterology. 2005 Jul-Aug;52(64):1053-6.

    PMID: 16001628BACKGROUND

MeSH Terms

Conditions

Lung Neoplasms

Interventions

Electrocoagulation

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

CauteryTherapeuticsAblation TechniquesSurgical Procedures, Operative

Study Officials

  • Joseph Newton, MD

    Sentara Cardiovascular Research Institute

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Laura Pine, RN, BSN

CONTACT

Michelle Collier, RN, BSN

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 26, 2007

First Posted

January 11, 2008

Study Start

December 1, 2007

Primary Completion

November 1, 2024

Study Completion

November 1, 2024

Last Updated

November 21, 2023

Record last verified: 2023-11

Locations